Functional studies in rat models have demonstrated that injection of GLP-1 has a dose-dependent effect on reducing feeding behaviors [54, 55], providing evidence of its function as a satiety mediator
The Ca 2+ /calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases
Oral dosing is viable especially for GI-specific issues -- ulcers, IBD, NSAID-induced gut damage (Sikiric, 1999)
Case Overview People are filing gastroparesis lawsuits after using GLP-1 drugs like Ozempic, Wegovy and Mounjaro
We urge regulators to enforce laws designed to protect public health." Taking action to protect patients To date, Novo Nordisk has filed 132 complaints in federal courts across 40 states, targeting companies whose illegal marketing and business practices put patient safety at risk
Marianne McDonagh #ingredient #supplements #diet #science Reported by William Bradford Nichols Click the link in the comments to read the full article To view or add a comment, sign in When Two Kiwis a Day Become Evidence-Based Medicine Last week, I was tucking into my usual after lunch sweet treat, a tub of kiwis and mango, when a colleague commented on how good they looked